These data suggest that both general adiposity and abdominal adiposity are associated with the risk of death and support the use of waist circumference or waist-to-hip ratio in addition to BMI in assessing the risk of death.
The genetic architecture of common traits, including the number,
frequency, and effect sizes of inherited variants that contribute to individual
risk, has been long debated. Genome-wide association studies have identified
scores of common variants associated with type 2 diabetes, but in aggregate,
these explain only a fraction of heritability. To test the hypothesis that
lower-frequency variants explain much of the remainder, the GoT2D and T2D-GENES
consortia performed whole genome sequencing in 2,657 Europeans with and without
diabetes, and exome sequencing in a total of 12,940 subjects from five ancestral
groups. To increase statistical power, we expanded sample size via genotyping
and imputation in a further 111,548 subjects. Variants associated with type 2
diabetes after sequencing were overwhelmingly common and most fell within
regions previously identified by genome-wide association studies. Comprehensive
enumeration of sequence variation is necessary to identify functional alleles
that provide important clues to disease pathophysiology, but large-scale
sequencing does not support a major role for lower-frequency variants in
predisposition to type 2 diabetes.
Objective To examine whether adherence to the modified Mediterranean diet, in which unsaturates were substituted for monounsaturates, is associated with longer life expectancy among elderly Europeans. Design Multicentre, prospective cohort study. Setting Nine European countries
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.